Spatiotemporal Clusters and Trends of Pneumocystis Pneumonia in Korea

키워드

참고문헌 (52)

1. K Grimwade, "Cotrimoxazole prophylaxis for opportunistic infections in children with HIV infection", Cochrane Database of Systematic Reviews, pp.CD003508~ (2003), John Wiley & Sons, Ltd[DOI]
2. Jonathan E. Kaplan, "Epidemiology of Human Immunodeficiency Virus–Associated Opportunistic Infections in the United States in the Era of Highly Active Antiretroviral Therapy", Clinical Infectious Diseases, 30(s1), pp.S5~S14 (2000), Oxford University Press (OUP)[DOI]
3. Alison Morris, "Current Epidemiology of<i>Pneumocystis<", i>Pneumonia, 2004, pp.10(10), 1713~1720[DOI]
4. Hye-Young Lee, "Epidemiologic Trends and Clinical Features of &lt;i&gt;Pneumocystis jirovecii&lt;", i&gt; Pneumonia in Non-HIV Patients in a Tertiary-Care Hospital in Korea over a 15-Year-Period, 2019, pp.72(4), 270~273[DOI]
5. Hyun-Ju Seo, "A newly developed tool for classifying study designs in systematic reviews of interventions and exposures showed substantial reliability and validity", Journal of Clinical Epidemiology, 70, pp.200~205 (2016), Elsevier BV[DOI]
6. Martin Kulldorff, "A spatial scan statistic", Communications in Statistics - Theory and Methods, 26(6), pp.1481~1496 (1997), Informa UK Limited[DOI]
7. J. STELLING, "Automated use of WHONET and SaTScan to detect outbreaks of <i>Shigella<", i> spp. using antimicrobial resistance phenotypes, 2009, pp.138(6), 873~883[DOI]
8. Robert W. Mathes, "Evaluating and implementing temporal, spatial, and spatio-temporal methods for outbreak detection in a local syndromic surveillance system", PLOS ONE, 12(9), pp.e0184419~ (2017), Public Library of Science (PLoS)[DOI]
9. Jin Chen, "Geovisual analytics to enhance spatial scan statistic interpretation: an analysis of U.S. cervical cancer mortality", International Journal of Health Geographics, 7(1), pp.57~74 (2008), Springer Science and Business Media LLC[DOI]
10. Martin Kulldorff, "Spatial disease clusters: Detection and inference", Statistics in Medicine, 14(8), pp.799~810 (1995), Wiley[DOI]
11. Wang W, "Using the maximum clustering heterogeneous set-proportion to select the maximum window size for the spatial scan statistic", Sci Rep, 10, pp.4900~4913 (2020)[DOI]
12. 유해린, "Optimizing the maximum reported cluster size for normal-based spatial scan statistics", Communications for Statistical Applications and Methods, 25(4), pp.373~383 (2018), 한국통계학회
13. Muluken Azage, "Childhood Diarrhea Exhibits Spatiotemporal Variation in Northwest Ethiopia: A SaTScan Spatial Statistical Analysis", PLOS ONE, 10(12), pp.e0144690~ (2015), Public Library of Science (PLoS)[DOI]
14. Limin X. Clegg, "Estimating average annual per cent change in trend analysis", Statistics in Medicine, 28(29), pp.3670~3682 (2009), Wiley[DOI]
15. Hyune-Ju Kim, "Permutation tests for joinpoint regression with applications to cancer rates", Statistics in Medicine, 19(3), pp.335~351 (2000), Wiley[DOI]
16. Anamaria Molnar, "A Joinpoint Regression Analysis of Syphilis and Gonorrhea Incidence in 15–19-Year Old Adolescents between 2005 and 2017: A Regional Study", International Journal of Environmental Research and Public Health, 17(15), pp.5385~5396 (2020), MDPI AG[DOI]
17. Hye-Young Lee, "Epidemiologic Trends and Clinical Features of &lt;i&gt;Pneumocystis jirovecii&lt;", i&gt; Pneumonia in Non-HIV Patients in a Tertiary-Care Hospital in Korea over a 15-Year-Period, 2019, pp.72(4), 270~273[DOI]
18. 최윤수, "Epidemiological characteristics of HIV infected Korean: Korea HIV", AIDS Cohort Study, 2019, pp.41, 1~9[DOI]
19. "Health and Medical Resources Survey"[URL]
20. Cristian Vera, "Transmission and Colonization of Pneumocystis jirovecii", Journal of Fungi, 7(11), pp.979~994 (2021), MDPI AG[DOI]
21. Magali Chabé, "La transmission des infections à<i>Pneumocystis<", i>, sciences, pp.2012, 28(6-7)[DOI]
22. F. Gigliotti, "Characterization of Transmission of <i>Pneumocystis carinii<", i> f. sp. <i>muris<, c Mice, pp.Infection and Immunity, 2003[DOI]
23. A. Dumoulin, "Transmission of Pneumocystis carinii   Disease from Immunocompetent Contacts of Infected Hosts to Susceptible Hosts", European Journal of Clinical Microbiology &amp; Infectious Diseases, 19(9), pp.671~678 (2000), Springer Science and Business Media LLC[DOI]
24. Magdalena Sokulska, "Pneumocystis jirovecii—from a commensal to pathogen: clinical and diagnostic review", Parasitology Research, 114(10), pp.3577~3585 (2015), Springer Science and Business Media LLC[DOI]
25. R.F. Miller, "Climate and genotypes of Pneumocystis jirovecii", Clinical Microbiology and Infection, 13(4), pp.445~448 (2007), Elsevier BV[DOI]
26. Peter D. Walzer, "The Ecology of<i>Pneumocystis<", i>: Perspectives, Personal Recollections, and Future Research Opportunities, 2013, pp.60(6), 634~645[DOI]
27. Albert Dunbar, "Epidemiology of Pneumocystis jirovecii Pneumonia and (Non-)use of Prophylaxis", Frontiers in Cellular and Infection Microbiology, 10, pp.224~230 (2020), Frontiers Media SA[DOI]
28. Philip B. Andreasen, "Pneumocystis jirovecii pneumonia in liver transplant recipients in an era of routine prophylaxis", Immunity, Inflammation and Disease, 10(1), pp.93~100 (2021), Wiley[DOI]
29. Shirley Chiu Wai Chan, "Epidemiology, mortality and effectiveness of prophylaxis for Pneumocystis jiroveci pneumonia among rheumatic patients: a territory-wide study", Annals of Clinical Microbiology and Antimicrobials, 20(1), pp.78~84 (2021), Springer Science and Business Media LLC[DOI]
30. Timothy L. Pruett, "Pneumocystis jirovecii: The Changing Landscape for Prophylaxis", Transplantation, 105(10), pp.2142~2143 (2021), Ovid Technologies (Wolters Kluwer Health)[DOI]
31. Organ Transplantation and Human Tissue Donation Statistics Annual Report 2020, "National Institute of Organ, Tissue, Blood Management", National Institute of Organ, Tissue, Blood Management, ~ (2020)
32. 오수진, "Aging and the Immune System: the Impact of Immunosenescence on Viral Infection, Immunity and Vaccine Immunogenicity", Immune Network, 19(6), pp.1~18 (2019), 대한면역학회[DOI]
33. Varnica Bajaj, "Aging, Immunity, and COVID-19: How Age Influences the Host Immune Response to Coronavirus Infections?", Frontiers in Physiology, 11, pp.571416~ (2021), Frontiers Media SA[DOI]
34. Hong Hong, "Aging, Cancer and Immunity", Journal of Cancer, 10(13), pp.3021~3027 (2019), Ivyspring International Publisher[DOI]
35. Hefziba Green, "Prophylaxis of Pneumocystis Pneumonia in Immunocompromised Non-HIV-Infected Patients: Systematic Review and Meta-analysis of Randomized Controlled Trials", Mayo Clinic Proceedings, 82(9), pp.1052~1059 (2007), Elsevier BV[DOI]
36. Xia Lin, "Prescription of <i>Pneumocystis Jiroveci<", i> Pneumonia Prophylaxis in HIV-Infected Patients, 2016, pp.15(6), 455~458[DOI]
37. Anat Stern, "Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients", Cochrane Database of Systematic Reviews, pp.CD005590~ (2014), Wiley[DOI]
38. Saba Radhi, "Outcome of HIV-associated Pneumocystis pneumonia in hospitalized patients from 2000 through 2003", BMC Infectious Diseases, 8(1), pp.118~127 (2008), Springer Science and Business Media LLC[DOI]
39. L Huang, "Suspected Pneumocystis carinii pneumonia with a negative induced sputum examination. Is early bronchoscopy useful?", American Journal of Respiratory and Critical Care Medicine, 151(6), pp.1866~1871 (1995), American Thoracic Society[DOI]
40. Magdalena Sokulska, "Genotyping of Pneumocystis jirovecii in colonized patients with various pulmonary diseases", Medical Mycology, 56(7), pp.809~815 (2017), Oxford University Press (OUP)[DOI]
41. Nobuhiro Asai, "Pathophysiological mechanism of non-HIV Pneumocystis jirovecii pneumonia", Respiratory Investigation, 60(4), pp.522~530 (2022), Elsevier BV[DOI]
42. Ting Xue, "Genetic Polymorphisms of <i>Pneumocystis jirovecii<", i> in HIV-Positive and HIV-Negative Patients in Northern China, 2022, pp.71(1), 27~34[DOI]
43. Alexandre Alanio, "Diversity of Pneumocystis jirovecii Across Europe: A Multicentre Observational Study", EBioMedicine, 22, pp.155~163 (2017), Elsevier BV[DOI]
44. Anish P Mahajan, "Stigma in the HIV", AIDS epidemic: a review of the literature and recommendations for the way forward, 2008, pp.22(Suppl 2), S67~S79[DOI]
45. Nelsensius Klau Fauk, "Stigma and Discrimination towards People Living with HIV in the Context of Families, Communities, and Healthcare Settings: A Qualitative Study in Indonesia", International Journal of Environmental Research and Public Health, 18(10), pp.5424~5440 (2021), MDPI AG[DOI]
46. Kim June Myung, "History of Acquired Immune Deficiency Syndrome in Korea", Infection and Chemotherapy, 52(2), pp.234~244 (2020), 대한감염학회[DOI]
47. M.-d. Oh, "Spectrum of Opportunistic Infections and Malignancies in Patients with Human Immunodeficiency Virus Infection in South Korea", Clinical Infectious Diseases, 29(6), pp.1524~1528 (1999), Oxford University Press (OUP)[DOI]
48. JuneMyungKim, "Epidemiology and Clinical Features of HIV Infection", AIDS in Korea, 2003, pp.44(3), 363~370[DOI]
49. Kwangwoo Nam, "Incidence and risk factors of Pneumocystis jirovecii pneumonia in Korean patients with inflammatory bowel disease", Journal of Gastroenterology and Hepatology, 35(2), pp.218~224 (2019), Wiley[DOI]
50. Gongmyung Lee, "Comparison of early and late Pneumocystis jirovecii Pneumonia in kidney transplant patients: the Korean Organ Transplantation Registry (KOTRY) Study", Scientific Reports, 12(1), pp.10682~11069 (2022), Springer Science and Business Media LLC[DOI]
51. 김윤정, "Opportunistic diseases among HIV-infected patients: a multicenter-nationwide Korean HIV", AIDS cohort study, 2006 to 2013, 2016, pp.31(5), 953~960[DOI]
52. 최은영, "류마티스관절염 환자에서 발생한 폐포자충 폐렴 1예", 대한류마티스학회지, 19(6), pp.359~363 (2012), 대한류마티스학회

관련 논문AI추천